Company: MIRM
Filing Date: 2025-08-12
Form Type: S-3ASR
Source: 0001193125-25-178937
Chunk: 65

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-3ASR
Chunk 65
---
 on the dates indicated.

| Name                  
 /s/ Christopher Peetz 
 Christopher Peetz     
 /s/ Eric Bjerkholt    
 Eric Bjerkholt        |     | Title                                                                   
 Chief Executive Officer and Director (Principal Executive Officer)      
 Chief Financial Officer (Principal Financial Officer)                   |     | Date            
 August 12, 2025 
 August 12, 2025 |
|:----------------------|:----|:------------------------------------------------------------------------|:----|:----------------|
| /s/ Jody Howe         
 Jody Howe             |     | Senior Vice President, Global Controller (Principal Accounting Officer) |     | August 12, 2025 |
| /s/ Laura Brege       
 Laura Brege           |     | Director                                                                |     | August 12, 2025 |
| /s/ Lon Cardon, Ph.D. 
 Lon Cardon, Ph.D.     |     | Director                                                                |     | August 12, 2025 |
| /s/ William C. Fairey 
 William C. Fairey     |     | Director                                                                |     | August 12, 2025 |

II-6

| Name                               
 /s/ Laurent Fischer, M.D.          
 Laurent Fischer, M.D.              
 /s/ Michael Grey                   
 Michael Grey                       |     | Title    
 Director 
 Director |     | Date            
 August 12, 2025 
 August 12, 2025 |
|:-----------------------------------|:----|:---------|:----|:----------------|
| /s/ Patrick Heron                  
 Patrick Heron                      |     | Director |     | August 12, 2025 |
| /s/ Saira Ramasastry, M.S., M.Phil 
 Saira Ramasastry, M.S., M.Phil     |     | Director |     | August 12, 2025 |
| /s/ Timothy Walbert                
 Timothy Walbert                    |     | Director |     | August 12, 2025 |

II-7